Generic Drug Alert: FDA Approves Generic Version of Precose for Type 2 Diabetes

Quick generic drug approval bulletin for today. If you have a family member or other loved suffers from Type 2 diabetes, the U.S. Food and Drug Administration has given Mylan Pharmaceuticals final approval for acarbose tablets, a generic version of Bayer’s prescription drug Precose which treats Type 2 diabetes. According to the American Diabetes Association, the possible complications of Type 2 diabetes include complications of the eyes, feet or skin.

Considering a thirty-day supply of brand-name Precose is currently running about $90, generic barcose tablets could easily be a major savings for the families of many Type 2 diabetes patients, so if someone in your family suffers from diabetes and is on Precose, you should ask their doctor if they are an appropriate candidate for the Precose generic counterpart.

Does someone in your family use Precose? Tell us about it!

Related posts:

1. Generic Drug Alert: FDA Approves Release of Generic Version of Protonix (Pantoprazole)
2. Generic Drug Alert: FDA Approves Generic Version of Lithobid
3. Generic Drug Alert: FDA Approves Generic Version of Lovenox Blood-Thinner
4. FDA Approves Generic Version of Blood Pressure Drug Plendil (Felodipine)
5. FDA Approves Generic Version of Aricept for Alzheimer’s To Be Sold Immediately